← Leaderboards
Mayland F Chang
University Of Notre Dame
$8,633,703
Attributed
$13,454,985
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2007–24$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$13,454,985 · 5
By mechanism
R01$10,720,307 · 4
T32$2,734,678 · 1
Top collaborators
- Shahriar Mobashery15 shared
- Marvin J Miller5 shared
Most similar at University Of Notre Dame
Same institution · by research overlap
- Shahriar Mobashery$28,662,632
- Renee Bouley$290,857
- Sandra Gesing$3,988,546
Others in their field
Top investigators on “Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$475,333,582
- Barton F Haynes · Duke University$444,977,767
- Lawrence Corey · Fred Hutchinson Cancer Center$334,646,086
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
StructureEvaluationIn VitroIn VivoPropertyCombinatorialProgramsInvestigationPharmaceutical PreparationsLeadPre-ClinicalDrug KineticsEnzymesGram-Positive BacteriaCessation Of LifeResistanceLibrariesAntibioticsAnti-Bacterial AgentsInfectionDesignBaseGrantInhibitor/Antagonist
Grant awards (26)
Spore germination pathway in Clostridioides difficile and its pharmacological intervention$770,512
R01 · FY2024 · AI · contact PI
Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame$289,762
T32 · FY2021 · GM · contact PI
Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame$289,234
T32 · FY2020 · GM · contact PI
The quinazolinone class of antibacterial agents$602,009
R01 · FY2019 · AI · contact PI
Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame$285,968
T32 · FY2019 · GM · contact PI
The quinazolinone class of antibacterial agents$602,009
R01 · FY2018 · AI · contact PI
Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame$282,780
T32 · FY2018 · GM · contact PI
The quinazolinone class of antibacterial agents$602,009
R01 · FY2017 · AI · contact PI
Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame$279,669
T32 · FY2017 · GM · contact PI
The quinazolinone class of antibacterial agents$602,009
R01 · FY2016 · AI · contact PI
Chemistry-Biochemistry-Biology Training Program at Notre Dame$271,579
T32 · FY2016 · GM · contact PI
The quinazolinone class of antibacterial agents$633,873
R01 · FY2015 · AI · contact PI
Chemistry-Biochemistry-Biology Training Program at Notre Dame$273,682
T32 · FY2015 · GM · contact PI
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria$990,528
R01 · FY2014 · AI · contact PI
Chemistry-Biochemistry-Biology Training Program at Notre Dame$270,804
T32 · FY2014 · GM · contact PI
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria$944,017
R01 · FY2013 · AI · contact PI
Chemistry-Biochemistry-Biology Training Program at Notre Dame$267,927
T32 · FY2013 · GM · contact PI
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria$1,016,761
R01 · FY2012 · AI · contact PI
Chemistry-Biochemistry-Biology Training Program at Notre Dame$223,273
T32 · FY2012 · GM · contact PI
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria$1,019,120
R01 · FY2011 · AI · contact PI
Intervention of Disease by Selective Gelatinase Inhibitors$364,376
R01 · FY2011 · CA
Novel oxadiazols for the treatment of drug-resistant gram-positive bacteria$1,069,649
R01 · FY2010 · AI · contact PI
Intervention of Disease by Selective Gelatinase Inhibitors$380,625
R01 · FY2010 · CA
Intervention of Disease by Selective Gelatinase Inhibitors$378,191
R01 · FY2009 · CA
Intervention of Disease by Selective Gelatinase Inhibitors$372,202
R01 · FY2008 · CA
Intervention of Disease by Selective Gelatinase Inhibitors$372,417
R01 · FY2007 · CA